针对动脉样硬化中的衰老细胞:通往新疗法的途径
Yuhan Tian1, Sihang Shao2, Haibo Feng3
1College of Pharmacy, Key Laboratory of Research and Application of Ethnic Medicine Processing and Preparation on the Qinghai-Tibet Plateau, Southwest Minzu University, Chengdu 610041, China.
Ageing research reviews
|September 15, 2024
概括
准衰老细胞为诸如动脉样硬化等与年龄相关的疾病提供了一种新方法. 治疗的目的是去除或抑制这些细胞,可能减缓心血管疾病的进展.
科学领域:
- 心血管研究研究心血管研究
- 细胞衰老 细胞衰老
- 免疫学 免疫学 免疫学
背景情况:
- 动脉样硬化是心血管疾病的主要原因之一.
- 衰老细胞有助于动脉样硬化发展.
- 衰老相关的分泌表型 (SASP) 促进炎症.
研究的目的:
- 审查衰老细胞在动脉样硬化中的作用.
- 总结针对动脉样硬化的衰老细胞的治疗策略.
- 探索心血管疾病的新型治疗途径.
主要方法:
- 关于细胞衰老和动脉样硬化的文献综述.
- 在疾病进展中分析SASP机制.
- 老年疗法药物和免疫疗法的概述.
主要成果:
- 衰老细胞通过DNA损伤,氧化应激和SASP促进动脉样硬化.
- 老年疗法和免疫疗法是新兴的治疗方法.
- 这些疗法旨在消除衰老细胞或减轻SASP.
结论:
- 向衰老细胞是动脉样硬化的一种有前途的策略.
- 高龄化药物和免疫疗法可能减缓或缓解心血管疾病.
- 这种方法为心血管研究和治疗开辟了新的途径.
相关概念视频
01:38Inflammation
53.2K
Overview
53.2K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K